🇺🇸 FLAG-IDA in United States

35 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 35

Most-reported reactions

1. Off Label Use — 6 reports (17.14%)
2. Drug Ineffective — 5 reports (14.29%)
3. Acute Myeloid Leukaemia Recurrent — 4 reports (11.43%)
4. Death — 4 reports (11.43%)
5. Pyrexia — 4 reports (11.43%)
6. Acute Lymphocytic Leukaemia — 3 reports (8.57%)
7. Febrile Neutropenia — 3 reports (8.57%)
8. Acute Lymphocytic Leukaemia Recurrent — 2 reports (5.71%)
9. Acute Myeloid Leukaemia — 2 reports (5.71%)
10. Hepatic Failure — 2 reports (5.71%)

Source database →

Frequently asked questions

Is FLAG-IDA approved in United States?

FLAG-IDA does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for FLAG-IDA in United States?

Sunshine Lake Pharma Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.